Doctors left shocked after clinical trial for cancer drug cures the disease in every participant
A new colorectal cancer drug has shocked researchers with how effective it is against the highly dangerous disease, as it virtually cured it in every member of a clinical trial.Dostarlimab, a monoclonal antibody drug, smashed expectations…